I can always tell when he has gone apoplectic by all the unread messages piling up at the bottom of the page. What stick got in his craw this time, the Sharoky news?
I suspect some of the board might follow. The market and the analysts will respond positively. Assuming we are in-market selling by Q4 of next year they should move up the timeline for revenue and run a discounted cash flow model. If, in fact, aggregate European/Asian/African cases are what has been posted close to 10,000 cases of NTM should be revenue generating (around 10% of afflicted).. At $16,000 per 12 week dosing and an average of 26 weeks on the program it amounts to $320 million in revenues. Add in Arikace being added to the CF regimen in Europe and we're looking at between $400 and $500 million in sales through july 1, 2015 and over $1 billion in all of 2015. This generates a valuation of between $5 billion and $6 billion, discounted by 20% or between $4 billion and $4.8 billion or as much as $100/share on the discounted cash flow model and 48 million shares. Here's hoping.
Sentiment: Strong Buy
Yep. Looks like an open market buy as opposed to Options Exercised.
Real nice. Undeniably positive event...and dare I say, bullish?
Will be even better if we see a slew of other open market buys as we are now, obviously, in the period for Insiders to buy, etc.
All this angry psychobabble jagoff9000, what the heck? (And to think you were supposed to have been a stain on the carpet...)
We have Lewis Cohen and Sharoky.all NuYorkers with cheap shares Selling price $17 to 20 dollars.Then they get a Novartis kickback for selling cheap.After all these years us old timers know these crooks for what they are.Read the ICOS biotech story.They sold the company and got Lilly kickbacks,SH took a 30% haircut filed a lawsuit but ICOS had enough votes to sell cheap.Thissucks